ACADIA PHARMACEUTICALS INC (ACAD)
$29.17-$0.56 (-1.88%) Today
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 48,120 | $1.32M |
| Grant or award | 4 | 101,260 | |
| Option exercise | 6 | 104,826 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
53 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 5,849 | $17.84 | $104K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 5,849 | $29.00 | $170K | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 14,292 | $17.84 | $255K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 5,000 | $29.00 | $145K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 9,292 | $29.34 | $273K | |
| Mark C. Schneyer - Officer | Option exercise | Stock Option (Right to Buy) | 5,849 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Stock Option (Right to Buy) | 14,292 | $0.00 | - | |
| Elizabeth H.Z. Thompson - Officer | Option exercise | Common Stock | 32,272 | - | - | |
| Elizabeth H.Z. Thompson - Officer | Open-market sale | Common Stock | 16,508 | $26.13 | $431K | |
| Elizabeth H.Z. Thompson - Officer | Open-market sale | Common Stock | 50 | $26.17 | $1K | |
| Elizabeth H.Z. Thompson - Officer | Option exercise | Restricted Stock Units | 32,272 | $0.00 | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 11,421 | $26.08 | $298K | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 18,622 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 18,622 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 32,008 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 32,008 | $0.00 | - | |
| Edmund Harrigan | Option exercise | Common Stock | 8,107 | - | - | |
| Edmund Harrigan | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Edmund Harrigan | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Edmund Harrigan | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| Adora Ndu | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| Adora Ndu | Option exercise | Common Stock | 8,107 | - | - | |
| Adora Ndu | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Adora Ndu | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Laura Brege | Option exercise | Common Stock | 8,107 | - | - | |
| Laura Brege | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Laura Brege | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Laura Brege | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| Jonathan Poole | Option exercise | Common Stock | 2,010 | - | - | |
| Jonathan Poole | Option exercise | Restricted Stock Units | 2,010 | $0.00 | - | |
| Jonathan Poole | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Jonathan Poole | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| Elizabeth A. Garofalo | Option exercise | Common Stock | 8,107 | - | - | |
| Elizabeth A. Garofalo | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| Elizabeth A. Garofalo | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| Elizabeth A. Garofalo | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| James M. Daly | Option exercise | Common Stock | 8,107 | - | - | |
| James M. Daly | Option exercise | Restricted Stock Units | 8,107 | $0.00 | - | |
| James M. Daly | Grant or award | Director Stock Options (Right to Buy) | 16,004 | $0.00 | - | |
| James M. Daly | Grant or award | Restricted Stock Units | 9,311 | $0.00 | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 5,401 | $21.18 | $114K | |
| James Kihara - Officer | Option exercise | Common Stock | 2,596 | - | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 1,332 | $21.79 | $29K | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 2,596 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 6,815 | - | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 3,506 | $21.79 | $76K | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 6,815 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 5,276 | - | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 2,709 | $22.20 | $60K | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 5,276 | $0.00 | - | |
| James Kihara - Officer | Option exercise | Common Stock | 2,010 | - | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 1,030 | $22.20 | $23K | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 2,010 | $0.00 | - | |
| Adams Catherine Owen - Officer | Option exercise | Common Stock | 23,509 | $0.00 | - | |
| Adams Catherine Owen - Officer | Open-market sale | Common Stock | 11,641 | $21.47 | $250K | |
| Adams Catherine Owen - Officer | Option exercise | Restricted Stock Units | 23,509 | $0.00 | - | |
| Elizabeth H.Z. Thompson - Officer | Option exercise | Common Stock | 6,715 | - | - | |
| Elizabeth H.Z. Thompson - Officer | Open-market sale | Common Stock | 3,435 | $21.47 | $74K | |
| Elizabeth H.Z. Thompson - Officer | Option exercise | Restricted Stock Units | 6,715 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Option exercise | Common Stock | 7,515 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Open-market sale | Common Stock | 3,844 | $21.47 | $83K | |
| Jennifer J. Rhodes - Officer | Option exercise | Restricted Stock Units | 7,515 | $0.00 | - | |
| James Kihara - Officer | Option exercise | Common Stock | 1,627 | - | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 833 | $21.47 | $18K | |
| James Kihara - Officer | Option exercise | Common Stock | 2,142 | - | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 1,097 | $21.65 | $24K | |
| James Kihara - Officer | Open-market sale | Common Stock | 12 | $21.73 | $261 | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 1,627 | $0.00 | - | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 2,142 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 8,138 | - | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 4,177 | $21.47 | $90K | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 3,171 | $21.65 | $69K | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 6,178 | - | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 37 | $21.72 | $804 | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 8,138 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 6,178 | $0.00 | - | |
| Jonathan Poole | Grant or award | Director Stock Options (Right to Buy) | 7,482 | $0.00 | - | |
| Jonathan Poole | Grant or award | Director Stock Options (Right to Buy) | 3,565 | $0.00 | - | |
| Jonathan Poole | Grant or award | Restricted Stock Units | 4,218 | $0.00 | - | |
| Jonathan Poole | Grant or award | Restricted Stock Units | 2,010 | $0.00 | - | |
| James Kihara - Officer | Grant or award | Restricted Stock Units | 6,332 | $0.00 | - | |
| James Kihara - Officer | Grant or award | Stock Option (Right to Buy) | 21,766 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Grant or award | Stock Option (Right to Buy) | 90,691 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Grant or award | Restricted Stock Units | 26,382 | $0.00 | - | |
| Mark C. Schneyer - Officer | Grant or award | Restricted Stock Units | 26,382 | $0.00 | - | |
| Mark C. Schneyer - Officer | Grant or award | Stock Option (Right to Buy) | 90,691 | $0.00 | - | |
| Thomas Garner - Officer | Grant or award | Restricted Stock Units | 28,493 | $0.00 | - | |
| Thomas Garner - Officer | Grant or award | Stock Option (Right to Buy) | 97,947 | $0.00 | - | |
| Elizabeth H.Z. Thompson - Officer | Grant or award | Stock Option (Right to Buy) | 101,574 | $0.00 | - | |
| Elizabeth H.Z. Thompson - Officer | Grant or award | Restricted Stock Units | 29,548 | $0.00 | - | |
| Adams Catherine Owen - Officer | Grant or award | Stock Option (Right to Buy) | 263,005 | $0.00 | - | |
| Adams Catherine Owen - Officer | Grant or award | Restricted Stock Units | 76,509 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Option exercise | Common Stock | 12,944 | $0.00 | - | |
| Jennifer J. Rhodes - Officer | Open-market sale | Common Stock | 6,950 | $23.38 | $162K | |
| Jennifer J. Rhodes - Officer | Option exercise | Restricted Stock Units | 12,944 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 9,913 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Restricted Stock Units | 9,913 | $0.00 | - | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 9,913 | - | - | |
| Mark C. Schneyer - Officer | Option exercise | Common Stock | 9,913 | - | - | |
| Mark C. Schneyer - Officer | Open-market sale | Common Stock | 10,262 | $23.69 | $243K | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 3,966 | $0.00 | - | |
| James Kihara - Officer | Option exercise | Common Stock | 3,966 | - | - | |
| James Kihara - Officer | Option exercise | Common Stock | 3,966 | - | - | |
| James Kihara - Officer | Open-market sale | Common Stock | 4,084 | $23.69 | $97K | |
| James Kihara - Officer | Option exercise | Restricted Stock Units | 3,966 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Schneyer Mark C. | Officer | 5,849 | $159K | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
ACADIA PHARMACEUTICALS INC (ACAD) had 4 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for ACAD runs to 53 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ACAD were filed in the last 90 days.
6 insider sales of ACAD were filed in the last 90 days, totaling $1.32M.
This page tracks ACAD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ACAD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
